Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 4201 - 4300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 4201 | 24965185 |
US |
1 | |
Overdose, |
||||
FENTANYL, |
||||
| 4202 | 24965245 |
US |
||
Unresponsive to stimuli, Cardiac arrest, Brain injury, Overdose, |
||||
FENTANYL, |
||||
| 4203 | 24965286 |
CA |
||
C-reactive protein abnormal, C-reactive protein increased, Confusional state, Drug hypersensitivity, Dyspnoea, Ill-defined disorder, Infusion related reaction, Injection site reaction, Nausea, Onychomadesis, Onychomycosis, Pain, Pemphigus, Pericarditis, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Swelling, Synovitis, Wound, Type 2 diabetes mellitus, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Drug ineffective, Underdose, Overdose, Contraindicated product administered, Product use issue, Product use in unapproved indication, Intentional product use issue, Intentional product use issue, Intentional product use issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DIATRIZOATE MEGLUMINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NEOMYCIN SULFATE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, POVIDONE-IODINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RETINOL, ASCORBIC ACID, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DESOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 4204 | 24966226 |
HU |
80 | 1 |
Choking, Hallucinations, mixed, Muscle spasms, Dysphagia, Loss of consciousness, Overdose, Confusional state, Somnolence, |
||||
CARBIDOPA, CARBIDOPA TABLETS, CARBIDOPA, CARBIDOPA TABLETS, CARBIDOPA AND LEVODOPA, |
||||
| 4205 | 24966282 |
US |
46 | 1 |
Erythema, Overdose, Swelling, Fatigue, Pain, |
||||
| 4206 | 24966608 |
FR |
1 | |
Thrombotic microangiopathy, COVID-19 pneumonia, Neurotoxicity, Renal impairment, Haematotoxicity, Drug interaction, Overdose, Hypertensive crisis, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, REMDESIVIR, NIRMATRELVIR AND RITONAVIR, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 4207 | 24966736 |
GB |
44 | 2 |
Overdose, Electrocardiogram T wave abnormal, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 4208 | 24966844 |
US |
||
Overdose, |
||||
CARIPRAZINE, |
||||
| 4209 | 24966863 |
US |
1 | |
Drug dependence, Drug abuse, Overdose, Toxicity to various agents, Loss of consciousness, Off label use, |
||||
FENTANYL CITRATE, FENTANYL CITRATE, ALPRAZOLAM, |
||||
| 4210 | 24966966 |
US |
53 | 2 |
Cerebrovascular accident, Brain injury, Seizure, Illness, Emotional disorder, Contusion, Overdose, |
||||
OLANZAPINE, OLANZAPINE PAMOATE, DULOXETINE HYDROCHLORIDE, INSULIN LISPRO, |
||||
| 4211 | 24967009 |
AU |
8 | 1 |
Overdose, Incorrect dose administered, Device use confusion, |
||||
RISPERIDONE, |
||||
| 4212 | 24957524 |
US |
48 | 2 |
Suicide attempt, Seizure, Overdose, Cardiac disorder, Migraine, Brain fog, |
||||
ADALIMUMAB, RISANKIZUMAB-RZAA, ETANERCEPT, |
||||
| 4213 | 24957553 |
CA |
32 | 2 |
COVID-19, Delirium, Diplegia, Ear infection, Gastroenteritis viral, Lip erythema, Lip pruritus, Lip swelling, Malaise, Mobility decreased, Oropharyngeal pain, Pain, Product availability issue, Psychotic disorder, Rash, Tooth disorder, Urticaria, Product dose omission issue, Off label use, Overdose, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LORATADINE, LORATADINE TABLET, |
||||
| 4214 | 24957954 |
CA |
2 | |
Pain, Infusion related reaction, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Joint swelling, Contraindicated product administered, Drug intolerance, Fluid retention, Foetal death, Temperature regulation disorder, Psoriasis, Intentional product misuse, Product use issue, Off label use, Treatment failure, Exposure during pregnancy, Overdose, Prescribed overdose, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, BUPROPION, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, FLUCONAZOLE, FUROSEMIDE, FUROSEMIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, ADALIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MORPHINE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ABATACEPT, ABATACEPT, ABATACEPT, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PSYLLIUM HUSK, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TEMAZEPAM, ALBUTEROL SULFATE, ALBUTEROL, CALCIUM SENNOSIDES, SENNOSIDES, SENNA LEAF, SENNA, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALBUTEROL SULFATE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, DOLUTEGRAVIR SODIUM, |
||||
| 4215 | 24958081 |
MZ |
21 | 1 |
Hepatotoxicity, Overdose, |
||||
MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PYRAZINAMIDE TABLET, PYRAZINAMIDE, ISONIAZID, |
||||
| 4216 | 24958360 |
CA |
33 | 2 |
Toxicity to various agents, Overdose, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, AMPHETAMINE, CAFFEINE, FENTANYL, RISPERIDONE, |
||||
| 4217 | 24958421 |
FI |
53 | 1 |
Asthenia, General physical health deterioration, Transient ischaemic attack, Overdose, |
||||
OLANZAPINE PAMOATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MELATONIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OLANZAPINE, |
||||
| 4218 | 24958440 |
US |
30 | 1 |
Drug abuse, Intentional product misuse, Mania, Overdose, Wrong technique in product usage process, |
||||
BUPROPION, BUPROPION, |
||||
| 4219 | 24958442 |
CN |
39 | 1 |
Overdose, Coma, Drug interaction, |
||||
BACLOFEN, CHLORPROMAZINE, |
||||
| 4220 | 24958457 |
JP |
64 | 2 |
Altered state of consciousness, Respiratory depression, Somnolence, Overdose, |
||||
TAPENTADOL HYDROCHLORIDE, RISPERIDONE, RISPERIDONE, TRAZODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 4221 | 24958487 |
US |
2 | |
Parkinson^s disease, Dementia, General physical health deterioration, Overdose, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 4222 | 24958530 |
CA |
82 | 2 |
Ventricular tachycardia, Arrhythmia, Chest discomfort, Chest pain, Fatigue, Hypotension, Overdose, Dizziness, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, FUROSEMIDE, ATORVASTATIN CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, ERGOCALCIFEROL, CALCIUM, FERROUS SULFATE, PEGFILGRASTIM, LEVOTHYROXINE SODIUM, |
||||
| 4223 | 24958832 |
US |
1 | |
Overdose, |
||||
NETARSUDIL, |
||||
| 4224 | 24959232 |
CZ |
63 | 1 |
Overdose, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 4225 | 24959623 |
IT |
76 | 1 |
Hyposmia, Sopor, Somnolence, Overdose, |
||||
| 4226 | 24960602 |
US |
1 | |
Overdose, Anxiety, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 4227 | 24960868 |
US |
||
Arrhythmic storm, Cardiogenic shock, Hypokalaemia, Ventricular fibrillation, Cardiac arrest, Overdose, Status epilepticus, |
||||
SERTRALINE, |
||||
| 4228 | 24960966 |
CA |
40 | 2 |
Decreased appetite, Hypersensitivity, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Overdose, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ERENUMAB-AOOE, APREMILAST, APREMILAST, CELECOXIB, CELECOXIB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, GOLIMUMAB, GOLIMUMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 4229 | 24960982 |
EU |
7 | 1 |
Sinusitis, Systemic mycosis, Cerebral aspergillosis, Infection, Disease progression, Acute kidney injury, Toxicity to various agents, Nausea, Off label use, Overdose, Off label use, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, ISAVUCONAZONIUM SULFATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 4230 | 24961002 |
IT |
88 | 2 |
Haemarthrosis, Catheter site haemorrhage, Gingival bleeding, Blood creatinine increased, Condition aggravated, Anaemia, Overdose, |
||||
APIXABAN, |
||||
| 4231 | 24961171 |
US |
24 | 2 |
Product storage error, Wrong technique in device usage process, Overdose, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 4232 | 24961292 |
PL |
||
Acute hepatic failure, Multiple organ dysfunction syndrome, Overdose, Acute kidney injury, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4233 | 24961379 |
PL |
||
Acute kidney injury, Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4234 | 24961390 |
CA |
2 | |
Food allergy, Hyperhidrosis, Immunodeficiency, Infusion related reaction, Joint swelling, Pain, Hypertension, Headache, Hypersensitivity, Hepatic enzyme increased, Exposure during pregnancy, Overdose, Prescribed overdose, Product use issue, Intentional product misuse, Off label use, |
||||
PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 4235 | 24961937 |
US |
27 | 2 |
Victim of homicide, Counterfeit product administered, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, FENTANYL, |
||||
| 4236 | 24962175 |
CA |
35 | 2 |
Overdose, |
||||
FENTANYL, CLOZAPINE, LOXAPINE, CLOZAPINE, |
||||
| 4237 | 24962635 |
US |
36 | 2 |
Cardiac arrest, Overdose, Toxicity to various agents, Cardiogenic shock, Arrhythmic storm, Status epilepticus, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 4238 | 24962668 |
JP |
||
Immobile, Back pain, Overdose, Off label use, |
||||
MONTELUKAST, |
||||
| 4239 | 24962703 |
US |
55 | 1 |
Seizure, Nasopharyngitis, Limb injury, Headache, Overdose, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 4240 | 24962720 |
CA |
2 | |
Asthma, Maternal exposure during pregnancy, Infection, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Thrombocytopenia, Upper respiratory tract infection, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, Back pain, Bursitis, Coeliac disease, Constipation, Contraindicated product administered, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Fatigue, Fluid retention, Foetal death, Hepatic enzyme increased, Immunodeficiency, Psoriasis, Temperature regulation disorder, Treatment failure, Dysphagia, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, |
||||
| 4241 | 24966009 |
69 | 1 | |
Respiratory depression, Sedation, Overdose, Unresponsive to stimuli, Drug use disorder, |
||||
OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, METHADONE HYDROCHLORIDE, METHADONE, CLONAZEPAM, |
||||
| 4242 | 24966300 |
|||
Overdose, |
||||
FENTANYL, |
||||
| 4243 | 24969577 |
60 | 2 | |
Confusional state, Sedation, Overdose, Pulmonary oedema, Depression, Suicidal ideation, |
||||
CYCLOBENZAPRINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 4244 | 24952864 |
HK |
12 | 1 |
Hepatotoxicity, Overdose, Thrombocytopenia, Disseminated intravascular coagulation, Metabolic acidosis, Hypoglycaemia, Shock, Vomiting, Diarrhoea, Mucous stools, Pyrexia, Lethargy, Hypotension, Haematemesis, Haematuria, Abdominal distension, Proteinuria, Renal tubular dysfunction, Renal failure, Ileus paralytic, Renal impairment, Rhabdomyolysis, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CEFACLOR, PROMETHAZINE, KAOLIN, KAOLIN, SACCHAROMYCES CEREVISIAE, |
||||
| 4245 | 24952866 |
US |
37 | 1 |
Seizure, Product dose omission issue, Overdose, |
||||
BRIVARACETAM, LACOSAMIDE, |
||||
| 4246 | 24953003 |
US |
53 | 2 |
Tremor, Overdose, Feeling abnormal, Symptom recurrence, Product dose omission issue, |
||||
GABAPENTIN, PROGESTERONE, PROGESTERONE, ESTRADIOL, |
||||
| 4247 | 24953030 |
FR |
55 | 1 |
Substance use disorder, Drug use disorder, Overdose, |
||||
ZOLPIDEM TARTRATE, METHADONE HYDROCHLORIDE, METHADONE, |
||||
| 4248 | 24953055 |
US |
36 | 2 |
Arrhythmic storm, Status epilepticus, Suicidal ideation, Overdose, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 4249 | 24953454 |
US |
82 | 1 |
Swelling, Incorrect product administration duration, Overdose, Wrong technique in product usage process, |
||||
LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 4250 | 24953501 |
US |
2 | |
Vision blurred, Intentional device misuse, Product dispensing issue, Device delivery system issue, Overdose, Wrong technique in product usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 4251 | 24953576 |
US |
1 | |
Death, Overdose, |
||||
| 4252 | 24954440 |
US |
73 | 2 |
Overdose, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, ADALIMUMAB, |
||||
| 4253 | 24955389 |
HK |
16 | 2 |
Lactic acidosis, Metabolic acidosis, Hypotension, Overdose, |
||||
AMLODIPINE, |
||||
| 4254 | 24955557 |
PL |
||
Overdose, Analgesic drug level increased, Blood ethanol increased, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 4255 | 24955625 |
HK |
16 | 2 |
Acute kidney injury, Toxicity to various agents, Metabolic acidosis, Lactic acidosis, Hypotension, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, AMLODIPINE, |
||||
| 4256 | 24955964 |
GB |
1 | |
Suicide attempt, Overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 4257 | 24956089 |
US |
0 | 1 |
Dyspnoea, Overdose, Drug withdrawal syndrome neonatal, Foetal exposure during pregnancy, |
||||
FENTANYL, FENTANYL, |
||||
| 4258 | 24956220 |
US |
2 | |
Unresponsive to stimuli, Overdose, Drug withdrawal syndrome neonatal, Foetal exposure during pregnancy, |
||||
FENTANYL, |
||||
| 4259 | 24956372 |
US |
1 | |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 4260 | 24956636 |
US |
26 | |
Victim of homicide, Overdose, |
||||
HYDROCODONE BITARTRATE, |
||||
| 4261 | 24956853 |
US |
1 | |
Overdose, Chest pain, Aggression, Abnormal behaviour, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 4262 | 24946232 |
CN |
85 | 2 |
Serotonin syndrome, Thrombocytopenia, Overdose, Drug level decreased, Hyperlactacidaemia, |
||||
LINEZOLID, LINEZOLID, |
||||
| 4263 | 24946234 |
CN |
72 | 1 |
Hyperlactacidaemia, Thrombocytopenia, Toxicity to various agents, Overdose, Drug level increased, |
||||
LINEZOLID, LINEZOLID, LEVAMLODIPINE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MEROPENEM, MEROPENEM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 4264 | 24946467 |
DE |
71 | 2 |
Coronavirus infection, Delirium, Hallucination, On and off phenomenon, Constipation, Sepsis, Nightmare, Weight decreased, Overdose, Apathy, Poor quality sleep, |
||||
PRAMIPEXOLE, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 4265 | 24946586 |
LK |
15 | 2 |
Bundle branch block right, Cardiotoxicity, Overdose, |
||||
ALBUTEROL SULFATE, ALBUTEROL, CHLORPHENIRAMINE MALEATE, |
||||
| 4266 | 24946648 |
CA |
40 | 2 |
Systemic lupus erythematosus, Neck pain, Onychomadesis, Overdose, Pain in extremity, Pemphigus, Pericarditis, Product label confusion, Pruritus, Psoriatic arthropathy, Rheumatic fever, Stomatitis, Swelling, Type 2 diabetes mellitus, Intentional product use issue, Dyspnoea, Finger deformity, Coeliac disease, Folliculitis, Drug-induced liver injury, Duodenal ulcer perforation, Gait inability, Fall, Confusional state, Contusion, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hypertension, Impaired healing, Ill-defined disorder, Inflammation, Injection site reaction, Infusion related reaction, Injury, Liver function test increased, Lower respiratory tract infection, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nail disorder, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, APREMILAST, APREMILAST, SULFASALAZINE, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, TOCILIZUMAB, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, HYDROXYCHLOROQUINE, TETRACYCLINE HYDROCHLORIDE, TETRACYCLINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, |
||||
| 4267 | 24946676 |
FR |
||
Bone marrow failure, Mucosal inflammation, Overdose, |
||||
RITUXIMAB, VINCRISTINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, CYTARABINE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 4268 | 24947183 |
US |
44 | 2 |
Toxicity to various agents, Suicide attempt, Multiple organ dysfunction syndrome, Respiratory failure, Hypotension, Hypertransaminasaemia, Lactic acidosis, Thrombocytopenia, Leukopenia, Acute kidney injury, Anuria, Overdose, Product use in unapproved indication, |
||||
COLCHICINE, |
||||
| 4269 | 24947429 |
US |
1 | |
Product use in unapproved indication, Therapeutic response unexpected, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 4270 | 24947530 |
CA |
40 | 2 |
Coeliac disease, Breast cancer stage III, Drug-induced liver injury, Duodenal ulcer perforation, Epilepsy, Hepatitis, Liver injury, Lower respiratory tract infection, Pemphigus, Pericarditis, Pneumonia, Drug ineffective, Contraindicated product administered, Maternal exposure during pregnancy, Off label use, Intentional product use issue, Overdose, Underdose, |
||||
SARILUMAB, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ATOMOXETINE HYDROCHLORIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 4271 | 24947632 |
US |
1 | |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 4272 | 24947773 |
US |
||
Overdose, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 4273 | 24947901 |
LK |
22 | 2 |
Cardiotoxicity, Sinus tachycardia, Overdose, |
||||
MONTELUKAST, |
||||
| 4274 | 24947910 |
LK |
24 | 1 |
Pulmonary haemorrhage, Renal disorder, Pulmonary oedema, Renal tubular necrosis, Toxicity to various agents, Overdose, |
||||
HALOPERIDOL, HALOPERIDOL LACTATE, OLANZAPINE, |
||||
| 4275 | 24947968 |
GB |
||
Myalgia, Product prescribing error, Overdose, |
||||
EZETIMIBE, |
||||
| 4276 | 24948180 |
GB |
1 | |
Product administered at inappropriate site, Overdose, |
||||
AFLIBERCEPT, AFLIBERCEPT, |
||||
| 4277 | 24948408 |
US |
1 | |
Device related infection, Spinal nerve stimulator implantation, Overdose, |
||||
ROTIGOTINE, |
||||
| 4278 | 24948674 |
CA |
58 | 2 |
Bursitis, Contraindicated product administered, Decreased immune responsiveness, Drug intolerance, Pyrexia, Rheumatoid arthritis, Thrombocytopenia, Asthma, Drug ineffective, Fatigue, Hyperhidrosis, Psoriasis, Constipation, Exposure during pregnancy, Hyponatraemia, Off label use, Overdose, Prescribed overdose, Hypersensitivity, Infusion related reaction, Product use issue, Retching, Temperature regulation disorder, Treatment failure, Hepatic enzyme increased, Immunodeficiency, Nausea, Rash erythematous, Back pain, Infection, Intentional product misuse, Rash, Drug hypersensitivity, Foetal death, Headache, Joint swelling, Pain, Coeliac disease, Erythema, Fluid retention, Food allergy, Hypertension, Upper respiratory tract infection, |
||||
MONTELUKAST SODIUM, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, PROGESTERONE, QUETIAPINE FUMARATE, QUETIAPINE, GABAPENTIN, BUPROPION HYDROCHLORIDE, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, FLUCONAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FUROSEMIDE, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ABATACEPT, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, TEMAZEPAM, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES, TEMAZEPAM, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, DICLOFENAC SODIUM, PREGABALIN, TOFACITINIB, MONTELUKAST SODIUM, MONTELUKAST, METHYLPREDNISOLONE ACETATE, |
||||
| 4279 | 24948771 |
KR |
57 | 1 |
Overdose, |
||||
VELPATASVIR AND SOFOSBUVIR, |
||||
| 4280 | 24949555 |
US |
||
Somnolence, Product use in unapproved indication, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, HYDROXYZINE, |
||||
| 4281 | 24949767 |
US |
2 | |
Blindness, Rosacea, Visual impairment, Arthropathy, Overdose, Hypersensitivity, Rash macular, Drug hypersensitivity, Drug effect less than expected, |
||||
ATOMOXETINE HYDROCHLORIDE, |
||||
| 4282 | 24949841 |
US |
||
Overdose, |
||||
INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, INCOBOTULINUMTOXINA, |
||||
| 4283 | 24949853 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Exposure during pregnancy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Live birth, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Folliculitis, Wound infection, Helicobacter infection, Incorrect route of product administration, Incorrect product administration duration, Medication error, Oedema, Ulcer haemorrhage, Swollen joint count increased, Weight decreased, Overdose, Osteoporosis, Oedema peripheral, Prescribed underdose, Rheumatic fever, Therapy non-responder, Treatment failure, |
||||
SARILUMAB, |
||||
| 4284 | 24950043 |
US |
||
Overdose, |
||||
INCOBOTULINUMTOXINA, |
||||
| 4285 | 24950099 |
SE |
89 | 1 |
Urinary retention, Seizure, Overdose, |
||||
ALLOPURINOL, FUROSEMIDE, |
||||
| 4286 | 24950238 |
US |
64 | 1 |
Overdose, Unresponsive to stimuli, Cardiac arrest, Brain injury, |
||||
FENTANYL CITRATE, |
||||
| 4287 | 24950511 |
CA |
51 | 1 |
Death, Toxicity to various agents, Overdose, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, AMPHETAMINE, AMPHETAMINE, AMPHETAMINE, AMPHETAMINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, FENTANYL, FENTANYL, FENTANYL, FENTANYL, NALOXONE, NALOXONE, NALOXONE, NALOXONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, |
||||
| 4288 | 24950697 |
US |
58 | 2 |
Overdose, Intentional product use issue, Incorrect product administration duration, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
| 4289 | 24950746 |
US |
2 | |
Overdose, Intentional product use issue, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
| 4290 | 24950893 |
US |
84 | 2 |
Overdose, Intentional product use issue, Incorrect product administration duration, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
| 4291 | 24951052 |
FR |
20 | 1 |
Coma, Toxicity to various agents, Somnolence, Drug abuse, Overdose, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 4292 | 24951760 |
US |
69 | 2 |
Dyspnoea, Malaise, Cough, Weight decreased, Illness, Overdose, Off label use, |
||||
TUCATINIB, TUCATINIB, TUCATINIB, TUCATINIB, CAPECITABINE, |
||||
| 4293 | 24952165 |
BR |
2 | |
Drug-induced liver injury, Overdose, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 4294 | 24952194 |
FR |
2 | |
Vomiting, Overdose, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 4295 | 24952237 |
FR |
57 | 2 |
Hepatic cytolysis, Cholestasis, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 4296 | 24952613 |
US |
33 | 2 |
Suicide attempt, Overdose, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, RISANKIZUMAB-RZAA, |
||||
| 4297 | 24945789 |
AU |
4 | 1 |
Overdose, Product dose confusion, |
||||
RISPERIDONE, |
||||
| 4298 | 24945981 |
US |
2 | |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 4299 | 24944372 |
CA |
||
Inflammatory marker increased, Vitamin B12 deficiency, Vitamin D deficiency, Blood iron decreased, Insulin resistance, Lower respiratory tract infection viral, Nasopharyngitis, Intentional dose omission, Drug effect less than expected, Intentional product use issue, Loss of therapeutic response, Pruritus, Overdose, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 4300 | 24944813 |
US |
||
Overdose, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30